Health Condition 1: null- Patients suffering from Diabetes
Conditions
Interventions
Intervention1: Grouup AIn this group, patients will be treated with drug prepared with Yava Rashi Nidhapita Bhallataka.
Dose : 500 mg in divided dose
Duration : 4 weeks
Mode of administration: Orally
Sponsors
IPGT and RA
Eligibility
Inclusion criteria
Inclusion criteria: • Patients having fasting blood sugar level>=126mg/dl or 2hrs. • Post prandial glucose level>=200mg/dl up to 600mg/dl
Exclusion criteria
Exclusion criteria: (A) Patients of Diabetes mellitus receiving Insulin. (B) Patients having chronic complications of Diabetes mellitus a. Microvascular: Retinopathy, Neuropathy and Nephropathy. b. Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. c. Other chronic debilitating disease like STD etc. (C) Pitta-Adhikya, Garbhini, Vimukta Raktatva, Trisna, Mukha Shosha, Anatamvana, Aalsi, Pramadi, Vyasani, Bhesajapmani.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Symptoms of Diabetes (Polyuria, Polydipsia & Polyphagia and weight loss) â?¢ Fasting Plasma glucose â?¥126mg/dl. â?¢ Two hour Plasma glucose â?¥200mg/dl during an oral glucose tolerance test. Timepoint: 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| exacerbation in signs and symptomsTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDr Mohan Krishna
IPGT and RA
Outcome results
None listed